Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.

Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70.

The aim of this study was to examine the specific chemoregimens selected for adjuvant therapy in the patients with stage III colon cancer. We investigated the trends in chemotherapeutic prescribing patterns and looked for adequate therapeutic setting for these patients.288 patients presenting with s...

Full description

Bibliographic Details
Main Authors:	Chieh-Sheng Lu, Ping-Ying Chang, Yu-Guang Chen, Jia-Hong Chen, Yi-Ying Wu, Ching-Liang Ho
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4575165?pdf=render

Similar Items

Adjuvant Chemotherapy for Stage III Colon Cancer
by: Julien Taieb, et al.
Published: (2020-09-01)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
by: Safiya Karim, et al.
Published: (2019-09-01)

Adjuvant Chemotherapy for Stage II Colon Cancer
by: Sara Elena Rebuzzi, et al.
Published: (2020-09-01)

Early discontinuation and dose reduction of adjuvant chemotherapy in stage III colon cancer patients
by: Daniel Boakye, et al.
Published: (2021-04-01)

Diabetes Alone should not be a Reason for Withholding Adjuvant Chemotherapy for Stage III Colon Cancer
by: Maren A. van Waalwijk, et al.
Published: (2011-01-01)

Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study
by: Peng Gao, et al.
Published: (2018-03-01)

Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair
by: Huabin Hu, et al.
Published: (2020-12-01)

Adjuvant chemotherapy for stage II colon cancer: who really needs it
by: Yang Y, et al.
Published: (2018-08-01)

Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer
by: Jianhong Peng, et al.
Published: (2020-09-01)

Adjuvant Chemotherapy for Patients with Stage Ⅱ Colon Cancer after Resection Surgery
by: Pei-Chen Pan, et al.
Published: (2019)

Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study.
by: Karen J Ortiz-Ortiz, et al.
Published: (2018-01-01)

Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis
by: Wen-Kuan Huang, et al.
Published: (2021-06-01)

Survival of Adjuvant Chemotherapy Among Elderly Patients with Stage II Colon Cancer
by: Tsung-Chih Tsai, et al.
Published: (2018-06-01)

The association of comorbidities with administration of adjuvant chemotherapy in stage III colon cancer patients: a systematic review and meta-analysis
by: Daniel Boakye, et al.
Published: (2021-01-01)

Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR patterns of care study
Published: (2009-01-01)

Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial
by: Yoshimura Kenichi, et al.
Published: (2013-01-01)

LINE-1 Methylation Status Correlates Significantly to Post-Therapeutic Recurrence in Stage III Colon Cancer Patients Receiving FOLFOX-4 Adjuvant Chemotherapy.
by: Yun-Ting Lou, et al.
Published: (2014-01-01)

The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
by: Alex Croese, et al.
Published: (2021-06-01)

Nutritional status predicts adjuvant chemotherapy outcomes for stage III colorectal cancer
by: Keisuke Ihara, et al.
Published: (2019-04-01)

The Optimal Duration of Adjuvant Chemotherapy in Colon Cancer
by: Maike Collienne, et al.
Published: (2020-09-01)

Postoperative Adjuvant Chemotherapy Regimen of CAPOX Combined With Ninjin'yoeito in an Elderly Patient With Stage III Colon Cancer: A Case Report
by: Naoki Aomatsu, et al.
Published: (2020-04-01)

Reasons physicians do not recommend and patients refuse adjuvant chemotherapy for stage III colon cancer: a population based chart review
by: El Shayeb Mohamed, et al.
Published: (2012-06-01)

Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer
by: Chen, Y., et al.
Published: (2022)

The role of adjuvant chemotherapy in stage I–III male breast cancer: a SEER-based analysis
by: Wei-Ping Li, et al.
Published: (2020-09-01)

Change in clinical outcomes during the transition of adjuvant chemotherapy for stage III colorectal cancer.
by: Hiroki Osumi, et al.
Published: (2017-01-01)

Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study
by: Hidetaka Kawamura, et al.
Published: (2020-01-01)

Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer
by: Ishiguro Megumi, et al.
Published: (2012-07-01)

Right- and left-sided stage III colon cancers present different prognostic outcomes of oxaliplatin-based adjuvant chemotherapy after curative resection
by: Peng J, et al.
Published: (2018-07-01)

Cognitive and physical function in individuals treated with adjuvant FOLFOX chemotherapy for colon cancer : pilot study
by: Niksirat, Negin
Published: (2014)

Effects of Timing of Adjuvant Treatment on Survival of Patients with Stage III Colon Cancer and Stage II/III Rectal Cancer in Alberta
by: Lima, Isac da S F
Published: (2010)

Adjuvant colon cancer chemotherapy: Is there an Indian standard of care?
by: Rohit Joshi
Published: (2013-01-01)

Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy.
by: Jang Ho Cho, et al.
Published: (2017-01-01)

Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population‐based study
by: Elizabeth Alwers, et al.
Published: (2020-02-01)

The Role of Tumor Deposits in Predicting the Efficacy of Chemotherapy in Stage III Colon Cancer
by: Mingyu Shi, et al.
Published: (2020-10-01)

Adjuvant chemotherapy in stage II–III operated colon cancer patients from a nontrial cohort in a low colon cancer prevalence country with predominant use of modified CAPOX
by: Anant Ramaswamy, et al.
Published: (2019-01-01)

Pathologic Factors Associated with Prognosis after Adjuvant Chemotherapy in Stage II/III Microsatellite-Unstable Colorectal Cancers
by: Jung Ho Kim, et al.
Published: (2015-03-01)

Adjuvant Chemotherapy and Tumor Sidedness in Stage II Colon Cancer: Analysis of the National Cancer Data Base
by: Shiva Kumar R. Mukkamalla, et al.
Published: (2020-09-01)

Effect of PRM1201 Combined With Adjuvant Chemotherapy on Preventing Recurrence and Metastasis of Stage III Colon Cancer: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: Ru Jia, et al.
Published: (2021-03-01)

Evaluation of the adverse effect profile of the adjuvant treatment in patients with stage II-III colon cancer
by: Kerim Çayır, et al.
Published: (2010-06-01)

Prognostic factors of adjuvant chemotherapy discontinuation among stage III colon cancer patients: A survey of medical oncologists and a systematic review and meta‐analysis
by: Devon J. Boyne, et al.
Published: (2020-03-01)